Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference

NEXT STORY
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
PREV STORY
Cullinan Management, Inc. Announces Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellectar Biosciences Announces Results of In Vivo Study Demonstrating PDC Platform Delivery of Paclitaxel to be Superior in Tumor Targeting to Free Paclitaxel

MADISON, Wis., June 15, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) ("the company"), ...

author_avatar
NASDAQ Market News

After the storm: keeping your pet safe after a hurricane

SEATTLE, Sept. 08, 2017 (GLOBE NEWSWIRE) -- Recovery after a hurricane takes time. Depending ...

author_avatar
NASDAQ Market News

Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights

Company reported net ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) sales of $7.0 million in ...

author_avatar
NASDAQ Market News